Skip to main content

Advertisement

SpringerLink
Log in

Treatment of prediabetic neuropathy

  • Clinical Trials Report
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Conclusions

The authors concluded that diet and exercise counseling for IGT results in some cutaneous reinnervation and improved painful symptoms. They also suggested that skin biopsy was a sensitive measure of neuropathy change over 1 year and that IENFD might be considered as an end point in future neuropathy trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boulton AJM, Malik RA, Arezzo J, Sosenko JM: Diabetic somatic neuropathies: a technical review. Diabetes Care 2004, 27:1458–1486.

    Article  PubMed  Google Scholar 

  2. Boulton AJM, Vinik AI, Arezzo J, et al.: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28:956–962.

    Article  PubMed  Google Scholar 

  3. Gregg EW, Sorlie P, Paulose-Ram R, et al.: Prevalence of lower-extremity disease in the US adult population greater than 40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:1591–1597.

    Article  PubMed  Google Scholar 

  4. Singleton JR, Smith AG, Bromberg MB: Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001, 24:1448–1453.

    Article  PubMed  CAS  Google Scholar 

  5. Sumner C, Seth S, Grif.n J, et al.: The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108–111.

    PubMed  CAS  Google Scholar 

  6. Rosenstock J, Tuchman M, La Moreaux I, Sharma U: Pregabalin for the treatment of painful diabetic neuropathy: a double-blind trial. Pain 2004, 110:628–634.

    Article  PubMed  CAS  Google Scholar 

  7. Goldstein DJ, Lu Y, Detke MJ, et al.: Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109–118.

    Article  PubMed  CAS  Google Scholar 

  8. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or met formin. N Engl J Med 2002, 346:393–403.

    Article  PubMed  CAS  Google Scholar 

  9. Oyibo S, Prasad YD, Jackson NJ, et al.: The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002, 19:870–873.

    Article  PubMed  CAS  Google Scholar 

  10. Malik RA, Kallinikos P, Abbott CA, et al.: Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003, 46:683–688.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Andrew J. M. Boulton MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boulton, A.J.M. Treatment of prediabetic neuropathy. Curr Diab Rep 6, 415–416 (2006). https://doi.org/10.1007/s11892-006-0072-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-006-0072-1

Keywords

Search

Navigation